Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Return on Assets (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Return on Assets for 3 consecutive years, with 0.72% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets fell 23.0% to 0.72% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.72%, a 23.0% decrease, with the full-year FY2024 number at 0.61%, down 20.0% from a year prior.
  • Return on Assets was 0.72% for Q3 2025 at Mereo BioPharma, up from 0.76% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.1% in Q3 2023 to a low of 0.76% in Q2 2025.
  • A 3-year average of 0.49% and a median of 0.49% in 2024 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: plummeted -39bps in 2024, then decreased -22bps in 2025.
  • Mereo BioPharma's Return on Assets stood at 0.25% in 2023, then plummeted by -111bps to 0.52% in 2024, then plummeted by -37bps to 0.72% in 2025.
  • Per Business Quant, the three most recent readings for MREO's Return on Assets are 0.72% (Q3 2025), 0.76% (Q2 2025), and 0.65% (Q1 2025).